Triplet therapy with ribociclib, everolimus, and exemestane in women with HR+/HER2- advanced breast cancer Meeting Abstract


Authors: Bardia, A.; Modi, S.; Oliveira, M.; Campone, M.; Ma, B.; Dirix, L.; Weise, A.; Nardi, L.; Zhang, V.; Bhansali, S. G.; Hewes, B.; Chavez-MacGregor, M.
Abstract Title: Triplet therapy with ribociclib, everolimus, and exemestane in women with HR+/HER2- advanced breast cancer
Meeting Title: 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 76
Issue: 4 Suppl.
Meeting Dates: 2015 Dec 8-12
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2016-02-15
Language: English
ACCESSION: WOS:000375622403351
DOI: 10.1158/1538-7445.sabcs15-p6-13-01
PROVIDER: wos
Notes: Meeting Abstract: P6-13-01 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Shanu Modi
    265 Modi